Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-1.36 Mil
% of Total Estimate Gain
-5.95%

SEVEN EIGHT CAPITAL, LP's Neurocrine Biosciences Inc Holding Summary

As of 2024-12-31, SEVEN EIGHT CAPITAL, LP held - shares of Neurocrine Biosciences Inc(NBIX), totaling N/A. This investment constitutes 0% of their stock portfolio, and SEVEN EIGHT CAPITAL, LP now holds 0% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.

The initial trade took place in 2015Q1. And since then SEVEN EIGHT CAPITAL, LP has made 12 purchases of NBIX, at an average price of $111.43, for a total of 205,314.00 shares. In addition, there have been 10 sales at an average price of $104.80 for 205,314.00 shares. Based on historical transaction data and NBIX's current price of $131.24, SEVEN EIGHT CAPITAL, LP's estimated gain on his NBIX holdings is $-1.36 Mil, reflecting a -5.95% gain to date.

SEVEN EIGHT CAPITAL, LP NBIX ($131.24) Holding Chart

SEVEN EIGHT CAPITAL, LP NBIX ($131.24) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1